1 document found, page 1 of 1

Sort by Issue Date

Personalized medicine: paradigm shift in ALK positive non-small cell lung cance...

Barreira, JV; Mendes, JL; Parmanande, A

Background: Since the identification of multiple therapeutic targets, as is the case of anaplastic lymphoma kinase (ALK) translocation, the paradigm of treating patients with non-small cell lung cancer (NSCLC) has improved. In order to guarantee the possibility of longer survival outcomes with a better quality of life we must invest in the determination, in suitable time, of the consensual biomarkers and in the...

Date: 2023   |   Origin: Saúde - CUF

1 Results

Queried text

Refine Results

Author




Date


Document Type


Access rights


Resource


Subject